Cargando…
Cost-effectiveness of an autoantibody test (EarlyCDT-Lung) as an aid to early diagnosis of lung cancer in patients with incidentally detected pulmonary nodules
OBJECTIVE: Patients who have incidentally detected pulmonary nodules and an estimated intermediate risk (5–60%) of lung cancer frequently are followed via computed tomography (CT) surveillance to detect nodule growth, despite guidelines for a more aggressive diagnostic strategy. We examined the cost...
Autores principales: | Edelsberg, John, Weycker, Derek, Atwood, Mark, Hamilton-Fairley, Geoffrey, Jett, James R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5963796/ https://www.ncbi.nlm.nih.gov/pubmed/29787590 http://dx.doi.org/10.1371/journal.pone.0197826 |
Ejemplares similares
-
EarlyCDT®-Lung test: improved clinical utility through additional autoantibody assays
por: Chapman, Caroline J., et al.
Publicado: (2012) -
Application of a High Throughput Method of Biomarker Discovery to Improvement of the EarlyCDT(®)-Lung Test
por: Macdonald, Isabel K., et al.
Publicado: (2012) -
Can autoantibody tests enhance lung cancer screening?—an evaluation of EarlyCDT(®)-Lung in context of the German Lung Cancer Screening Intervention Trial (LUSI)
por: González Maldonado, Sandra, et al.
Publicado: (2021) -
Detection in blood of autoantibodies to tumour antigens as a case-finding method in lung cancer using the EarlyCDT®-Lung Test (ECLS): study protocol for a randomized controlled trial
por: Sullivan, F. M., et al.
Publicado: (2017) -
Cost-effectiveness of a new autoantibody test added to Computed Tomography (CT) compared to CT surveillance alone in the diagnosis of lung cancer amongst patients with indeterminate pulmonary nodules
por: Sutton, Andrew John, et al.
Publicado: (2020)